Imagenebio Inc (IMA)

CUSIP: 45175G207 | NYSE | Healthcare · Biotechnology | Micro Cap | 56 institutional holders

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13G/ABVF Inc with BVF GP Holdings LLC, BVF I GP LLC, Biotechnology Value Fund L P, +4 more	1,128,647	9.9%	New 5%+ stake	Jun 30, 2026	No 13F filer matched
13DOtello Stampacchia

Institutional Holders — Q3 2026

Sort by

Caitong International Asset Management Co., Ltd464

0.0% of portfolio$2.1K

				Style	Turnover	Location	Filed
Caitong International Asset Management Co., Ltd	464	$2.1K	0.0%	Growth	Very High	Hong Kong, South Korea	2026-10-29

13G/ABVF Inc1,128,647

9.9% of class · Jun 30, 2026New 5%+ stake

with BVF GP Holdings LLC, BVF I GP LLC, Biotechnology Value Fund L P, +4 more

No 13F filer matched

13DOtello Stampacchia936,222

8.4% of class · Apr 14, 2026New 5%+ stake

with Omega Fund VI GP, L.P., Omega Fund VI GP Manager, Ltd., Omega Fund VI, L.P., +1 more

No 13F filer matched